Investigación

Dianas farmacológicas en inflamación y enfermedades metabólicas

Buscador de publicaciones

Publicaciones

  • Carrasco M, Guzman L, Olloquequi J, Cano A, Fortuna A, Vazquez M, Verdaguer E, Auladell C, Ettcheto M and Camins A.

    Licochalcone A prevents cognitive decline in a lipopolysaccharide-induced neuroinflammation mice model.

    MOLECULAR MEDICINE . 31(1): 54-54.

    [doi:10.1186/s10020-025-01106-8]

  • Montori M, Barroso E, Jurado-Aguilar J, Peyman M, Wahli W, Palomer FX and Vazquez M.

    Palmitate potentiates the SMAD3-PAI-1 pathway by reducing nuclear GDF15 levels.

    CELLULAR AND MOLECULAR LIFE SCIENCES . 82(1): 43-43.

    [doi:10.1007/s00018-024-05571-y]

  • Wang JR, Jurado-Aguilar J, Barroso E, Rodríguez-Calvo R, Camins A, Wahli W, Palomer FX and Vazquez M.

    PPARß/d upregulates the insulin receptor ß subunit in skeletal muscle by reducing lysosomal activity and EphB4 levels.

    CELL COMMUNICATION AND SIGNALING . 22(1): 595-595.

    [doi:10.1186/s12964-024-01972-5]

  • Rostami A, Palomer FX, Pizarro J, Barroso E, Valenzuela-Alcaraz BI, Crispi F, Nistal JF, Hurlé MA, García R, Wahli W and Vazquez M.

    PPARß/d prevents inflammation and fibrosis during diabetic cardiomyopathy

    PHARMACOLOGICAL RESEARCH . 210: 107515-107515.

    [doi:10.1016/j.phrs.2024.107515]

  • Barroso E, Jurado-Aguilar J, Wahli W, Palomer FX and Vazquez M.

    Increased hepatic gluconeogenesis and type 2 diabetes mellitus.

    TRENDS IN ENDOCRINOLOGY AND METABOLISM . 35(12): 1062-1077. Nº de citas: 6

    [doi:10.1016/j.tem.2024.05.006]

  • Guardiola M, Girona J, Barroso E, García-Altares M, Ibarretxe D, Plana N, Ribalta J, Correig X, Vazquez M, Masana L and Rodríguez-Calvo R.

    The GDF15 3' UTR Polymorphism rs1054564 Is Associated with Diabetes and Subclinical Atherosclerosis.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 25(22): .

    [doi:10.3390/ijms252211985]

  • Zhang M, Barroso E, Peña L, Rada P, Valverde ÁM, Wahli W, Palomer FX and Vazquez M.

    PPARß/d attenuates hepatic fibrosis by reducing SMAD3 phosphorylation and p300 levels via AMPK in hepatic stellate cells.

    BIOMEDICINE & PHARMACOTHERAPY . 179: 117303-117303. Nº de citas: 3

    [doi:10.1016/j.biopha.2024.117303]

  • Palomer FX, Salvador JM, Griñán-Ferré C, Barroso E, Pallàs M and Vazquez M.

    GADD45A: With or without you

    MEDICINAL RESEARCH REVIEWS . 44(4): 1375-1403. Nº de citas: 12

    [doi:10.1002/med.22015]

  • Peyman M, Babin-Ebell A, Rodríguez-Rodríguez R, Rigon M, Aguilar-Recarte D, Villarroya-Terrade J, Planavila A, Villarroya-Gombau F, Palomer FX, Barroso E and Vazquez M.

    SIRT1 regulates hepatic vldlr levels

    CELL COMMUNICATION AND SIGNALING . 22(1): 297-297. Nº de citas: 1

    [doi:10.1186/s12964-024-01666-y]

  • Pormohammad A, Moradi M, Hommes JW, Pujol E, Naesens L, Vázquez S, Surewaard BGJ, Zarei M, Vazquez M and Turner RJ.

    Novel pentafluorosulfanyl-containing triclocarban analogs selectively kill Gram-positive bacteria

    Microbiology spectrum . : . Nº de citas: 3

    [doi:10.1128/spectrum.00071-24]